S&P 500   2,992.51 (-0.11%)
DOW   27,017.49 (-0.03%)
QQQ   192.91 (-0.32%)
AAPL   233.89 (-0.61%)
FB   188.57 (-0.17%)
MSFT   139.94 (-1.15%)
AMZN   1,777.70 (+0.58%)
CGC   19.61 (-2.44%)
NVDA   197.06 (+0.35%)
MU   45.98 (-1.03%)
BABA   176.30 (+0.58%)
GE   9.00 (+1.24%)
TSLA   260.77 (+1.12%)
AMD   31.11 (+1.27%)
T   37.92 (+0.05%)
ACB   3.71 (-1.33%)
S&P 500   2,992.51 (-0.11%)
DOW   27,017.49 (-0.03%)
QQQ   192.91 (-0.32%)
AAPL   233.89 (-0.61%)
FB   188.57 (-0.17%)
MSFT   139.94 (-1.15%)
AMZN   1,777.70 (+0.58%)
CGC   19.61 (-2.44%)
NVDA   197.06 (+0.35%)
MU   45.98 (-1.03%)
BABA   176.30 (+0.58%)
GE   9.00 (+1.24%)
TSLA   260.77 (+1.12%)
AMD   31.11 (+1.27%)
T   37.92 (+0.05%)
ACB   3.71 (-1.33%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CASI PharmaceuticalsADMA BiologicsBioCryst PharmaceuticalsScholar RockCellular Biomedicine Group
SymbolNASDAQ:CASINASDAQ:ADMANASDAQ:BCRXNASDAQ:SRRKNASDAQ:CBMG
Price Information
Current Price$3.22$4.31$2.65$9.51$15.00
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$7.00$10.20$9.10$27.00$24.00
% Upside from Price Target117.39% upside136.66% upside243.40% upside183.91% upside60.00% upside
Trade Information
Market Cap$306.30 million$247.36 million$270.02 million$278.99 million$287.44 million
Beta1.122.711.950.042.84
Average Volume144,814916,1591,763,46469,22130,910
Sales & Book Value
Annual RevenueN/A$16.99 million$20.65 million$380,000.00$220,000.00
Price / SalesN/A15.0514.17742.781,312.50
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.15 per share$0.43 per share$0.45 per share$4.22 per share$4.63 per share
Price / BookN/A10.025.892.253.24
Profitability
Net Income$-27,470,000.00$-65,740,000.00$-101,250,000.00$-49,330,000.00$-38,930,000.00
EPS($0.32)($1.45)($0.98)($3.15)($2.04)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-323.54%-1,091.44%N/A-17,921.62%
Return on Equity (ROE)-34.21%-214.26%-371.33%-45.02%-44.32%
Return on Assets (ROA)-29.54%-58.58%-87.63%-29.78%-36.50%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.79%2.38%0.04%N/A
Current Ratio13.04%10.26%1.44%5.88%2.68%
Quick Ratio12.93%7.93%1.43%5.88%2.68%
Ownership Information
Institutional Ownership Percentage12.17%59.07%90.73%58.52%20.37%
Insider Ownership Percentage24.29%15.20%5.20%41.40%9.10%
Miscellaneous
Employees12431410065193
Shares Outstanding95.72 million59.32 million110.44 million29.68 million19.25 million
Next Earnings Date11/13/2019 (Estimated)11/14/2019 (Estimated)11/5/2019 (Estimated)11/13/2019 (Estimated)11/5/2019 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable
 CASI PharmaceuticalsADMA BiologicsBioCryst PharmaceuticalsScholar RockCellular Biomedicine Group

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel